Institutional shares held 52.6 Million
148K calls
70.7K puts
Total value of holdings $94.2M
$264K calls
$126K puts
Market Cap $109M
60,840,800 Shares Out.
Institutional ownership 86.5%
# of Institutions 135


Latest Institutional Activity in CRBU

Top Purchases

Q3 2024
Schonfeld Strategic Advisors LLC Shares Held: 1.65M ($2.95M)
Q3 2024
Kynam Capital Management, LP Shares Held: 2.36M ($4.22M)
Q3 2024
Pale Fire Capital Se Shares Held: 735K ($1.32M)
Q3 2024
Lynx1 Capital Management LP Shares Held: 680K ($1.22M)
Q3 2024
Morgan Stanley Shares Held: 1.2M ($2.14M)

Top Sells

Q3 2024
Renaissance Technologies LLC Shares Held: 594K ($1.06M)
Q3 2024
Dimensional Fund Advisors LP Shares Held: 2.05M ($3.68M)
Q3 2024
Goldman Sachs Group Inc Shares Held: 701K ($1.25M)
Q3 2024
Two Sigma Investments, LP Shares Held: 904K ($1.62M)
Q3 2024
Point72 Asset Management, L.P. Shares Held: 2.13M ($3.82M)

About CRBU

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1 clinical trial to treat relapsed or refractory B cell non-Hodgkin lymphoma; and CB-011, an allogeneic anti-BCMA CAR-T cell therapy for the treatment of relapsed or refractory multiple myeloma. The company also develops CB-012, an allogeneic anti-CD371 CAR-T cell therapy for the treatment of relapsed or refractory acute myeloid leukemia; and CB-020, an allogeneic CAR-NK cell therapy for the treatment of solid tumors. It has collaboration with AbbVie Manufacturing Management Unlimited Company to develop CAR-T cell therapies. The company was incorporated in 2011 and is headquartered in Berkeley, California.


Insider Transactions at CRBU

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
306K Shares
From 7 Insiders
Grant, award, or other acquisition 276K shares
Exercise of conversion of derivative security 30.6K shares
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on CRBU

Follow Caribou Biosciences, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CRBU shares.

Notify only if

Insider Trading

Get notified when an Caribou Biosciences, Inc. insider buys or sells CRBU shares.

Notify only if

News

Receive news related to Caribou Biosciences, Inc.

Track Activities on CRBU